Free Trial
OTCMKTS:PBSV

Pharma-Bio Serv (PBSV) Stock Price, News & Analysis

Pharma-Bio Serv logo
$0.58 -0.02 (-3.33%)
As of 07/10/2025 10:51 AM Eastern

About Pharma-Bio Serv Stock (OTCMKTS:PBSV)

Key Stats

Today's Range
$0.58
$0.58
50-Day Range
$0.43
$0.60
52-Week Range
$0.31
$0.67
Volume
2,020 shs
Average Volume
6,772 shs
Market Capitalization
$13.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

PBSV Stock News Headlines

PBSV Pharma-Bio Serv, Inc. - Seeking Alpha
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
PBSV Decisions Paying Off
PBSV Returns to Growth
PBSV Released Earnings and Declares Dividend
See More Headlines

PBSV Stock Analysis - Frequently Asked Questions

Pharma-Bio Serv's stock was trading at $0.5499 at the beginning of 2025. Since then, PBSV shares have increased by 5.5% and is now trading at $0.58.

Pharma-Bio Serv Inc. (OTCMKTS:PBSV) announced its earnings results on Monday, March, 17th. The company reported $0.37 EPS for the quarter, topping analysts' consensus estimates of $0.02 by $0.35. The business had revenue of $2.47 million for the quarter, compared to the consensus estimate of $2.70 million. Pharma-Bio Serv had a negative trailing twelve-month return on equity of 1.47% and a negative net margin of 1.96%.

Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pharma-Bio Serv investors own include AT&T (T), Annaly Capital Management (NLY), BlackRock Multi-Sector Income Trust (BIT), GE Aerospace (GE), Exxon Mobil (XOM), Enterprise Products Partners (EPD) and First BanCorp. (FBP).

Company Calendar

Last Earnings
3/17/2025
Today
7/11/2025
Next Earnings (Estimated)
9/15/2025
Fiscal Year End
10/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Consulting
Sub-Industry
Business Services
Current Symbol
OTCMKTS:PBSV
CIK
1304161
Employees
185
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
5.27
P/E Growth
N/A
Net Income
-$780 thousand
Net Margins
-1.96%
Pretax Margin
-2.01%
Return on Equity
-1.47%
Return on Assets
-1.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.54
Quick Ratio
7.54

Sales & Book Value

Annual Sales
$9.51 million
Price / Sales
1.40
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.60 per share
Price / Book
0.97

Miscellaneous

Outstanding Shares
22,930,000
Free Float
20,043,000
Market Cap
$13.30 million
Optionable
Not Optionable
Beta
0.68

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (OTCMKTS:PBSV) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners